An engineered bispecific nanobody in tetrameric secretory IgA format confers broad neutralization against SARS-CoV-1&2 and most variants
Weihong Zeng(Hefei University of Technology), Tengchuan Jin(Anhui Medical University), Yan Wu(Chinese Academy of Sciences), Xiaoying Jia(South Central Minzu University), Sandra Chiu(University of Science and Technology of China), Entao Li(University of Science and Technology of China), Xiaodong Ye(Shanghai Institute of Organic Chemistry), Xiangyang Chi(Academy of Military Medical Sciences), Jin Han(Academy of Military Medical Sciences), Kang Ni(University of Science and Technology of China), Yang Liu(Harbin Medical University), Changming Yu(Nanjing University of Chinese Medicine), Xinghai Zhang(Chinese Academy of Sciences), Huan Ma(University of Science and Technology of China), Xiaowen Hu(Lanzhou University)
Cited by 12
Related Papers
IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication
|Proceedings of the National Academy of Sciences|2013|342
Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
|Frontiers in Chemistry|2021|311
Authenticated key agreement scheme for fog-driven IoT healthcare system
|Wireless Networks|2018|249
An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies
|Oncogene|2010|229
BRAF V600E Expression in Langerhans Cell Histiocytosis
|The American Journal of Surgical Pathology|2014|162